Stay updated on PDR001 with Chemo and Immunology Agents in NSCLC Clinical Trial

Sign up to get notified when there's something new on the PDR001 with Chemo and Immunology Agents in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the PDR001 with Chemo and Immunology Agents in NSCLC Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The page’s displayed revision version was incremented from **v3.5.2** to **v3.5.3**, reflecting a site/version update without altering the study details shown.
    Difference
    0.0%
    Check dated 2026-04-24T05:55:25.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    The Spartalizumab publication citation was updated to Revision: v3.5.2 with an erratum added, replacing the previous Revision: v3.5.0.
    Difference
    0.1%
    Check dated 2026-04-17T02:31:58.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    32 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0 on the page.
    Difference
    0.0%
    Check dated 2026-03-26T11:26:45.000Z thumbnail image
  5. Check
    46 days ago
    Change Detected
    Summary
    Revision history updated: added Revision: v3.4.3 and removed Revision: v3.4.2.
    Difference
    0.0%
    Check dated 2026-03-12T00:47:08.000Z thumbnail image
  6. Check
    74 days ago
    Change Detected
    Summary
    Added site revision tag v3.4.2 and removed the prior funding/status notice (v3.4.1); these are maintenance updates to the site interface and do not affect trial content or user actions. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2026-02-11T13:57:32.000Z thumbnail image
  7. Check
    82 days ago
    Change Detected
    Summary
    Notice added about a lapse in government funding and NIH operating status with links to cc.nih.gov and opm.gov. The site revision was updated from v3.4.0 to v3.4.1.
    Difference
    0.3%
    Check dated 2026-02-04T07:54:30.000Z thumbnail image

Stay in the know with updates to PDR001 with Chemo and Immunology Agents in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the PDR001 with Chemo and Immunology Agents in NSCLC Clinical Trial page.